Zobrazeno 1 - 3
of 3
pro vyhledávání: '"L H Boer"'
Publikováno v:
The Journal of Immunology. 159:5545-5549
Bispecific Abs (BsAb) represent a novel format of immunotherapy, recognizing immune effector cells (e.g., T cells), on the one hand, and target cells (e.g., tumor cells), on the other hand. To be successful, cross-linking of the two cell types is nec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::815e0198ff7966caa76ca3a652a15c26
https://doi.org/10.4049/jimmunol.159.11.5545
https://doi.org/10.4049/jimmunol.159.11.5545
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(11)
Bispecific Abs (BsAb) represent a novel format of immunotherapy, recognizing immune effector cells (e.g., T cells), on the one hand, and target cells (e.g., tumor cells), on the other hand. To be successful, cross-linking of the two cell types is nec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1eac32f219eee02d33fb2e2eab0145c6
https://pubmed.ncbi.nlm.nih.gov/9548495
https://pubmed.ncbi.nlm.nih.gov/9548495
Publikováno v:
Scandinavian journal of immunology. 46(5)
Bispecific antibodies (BsAb) consist of two different heavy and light chains and may bind to two different antigens present on different cell types. With their dual specificity BsAb may recognize effector cells (e.g. T cells) on one hand and tumour c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035ab2a6eaf2bd7186ad6fb4130f8cee
https://pubmed.ncbi.nlm.nih.gov/9393627
https://pubmed.ncbi.nlm.nih.gov/9393627